This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Ursodeoxycholic acid may improve liver function and the patient's symptoms but no definitive improvement in histology or mortality or delay in liver transplant has been demonstrated (1).

 

Other measures include:

  • cholestyramine to relieve pruritus
  • correction of deficiencies of fat-soluble vitamins
  • percutaneous transhepatic balloon dilatation may be of benefit for dominant strictures

In cases where the disease is largely confined to the distal extrahepatic ducts and the proximal ducts are dilated, a Roux-en-Y hepatico-jejunostomy may be indicated.

Liver transplantation is potentially curative and is indicated where there is hepatic failure, ascites, or oesophageal varices. A 70% five-year survival is reported in major transplant centres but the timing of transplant and patient selection are critical. PSC recurrence in the newly transplanted liver has not so far been reported.

Colectomy for concurrent ulcerative colitis does not effect the outcome of liver damage.

Note that aout 20 per cent of patients will develop a dominant biliary stricture so it is important to exclude a cholangiocarcinoma (which is common) (1).

Reference:

  1. Prescriber 2003; 14(23):20-9.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.